Answer
There are no data on avalglucosidase alfa (Nexviadyme) use in pregnant women, its human risk and pregnancy safety are unknown, and it should be used during pregnancy only if potential benefits to the mother outweigh potential risks, including those to the foetus.
Sources for this answer
- Nexviadyme 100 mg powder for concentrate for solution for infusionSANOFI · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked